Watch: Mason Gooding's 'Scream VI' Workout

More in Health/Fitness

Kentucky Lawmakers Struggle to Finish Transgender Bill

Kentucky Lawmakers Struggle to Finish Transgender Bill

HEALTH | Mar 16, 2023

Kentucky GOP lawmakers struggled to wrap up a bill restricting gender-affirming care for minors, as internal differences complicated their push to beat a Thursday deadline to complete the sweeping proposal denounced by outside voices within their party.

When Will Medicare Cover Medical Marijuana?

When Will Medicare Cover Medical Marijuana?

HEALTH | By Kate Ashford | Mar 16, 2023

Many older adults use medical marijuana for a variety of conditions, but experts say that conflicting laws and complicated rulemaking mean it could be years before Medicare may cover the drug.

Former Kentucky Lawmaker Makes Plea on Gender-Affirming Care

Former Kentucky Lawmaker Makes Plea on Gender-Affirming Care

HEALTH | By Bruce Schreiner | Mar 15, 2023

For years, Jerry Miller was a fixture at legislative hearings in Kentucky, but this time was different: the GOP ex-lawmaker opened up about how his young grandchild could be hurt by a bill to ban access to gender-affirming medical care for those under 18.

Sanders Signs Arkansas Trans Care Malpractice Bill into Law

Sanders Signs Arkansas Trans Care Malpractice Bill into Law

HEALTH | By Andrew DeMillo | Mar 15, 2023

Arkansas Gov. Sarah Huckabee Sanders has signed legislation making it easier to sue providers of gender-affirming care for children, a move that could effectively reinstate a blocked ban on such care.

Abortion Pill Challenge Goes Before Judge in Texas

Abortion Pill Challenge Goes Before Judge in Texas

HEALTH | By Sean Murphy | Mar 15, 2023

A federal judge will hear arguments Wednesday in a high-stakes court case that could threaten access to medication abortion and blunt the authority of U.S. drug regulators.

Pfizer will Spend $43 Billion to Acquire Seagen

Pfizer will Spend $43 Billion to Acquire Seagen

HEALTH | By Tom Murphy | Mar 13, 2023

Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay $229 per Seagen share.

1 - 10 of 13030 Stories